24 employees
Kojin is a biopharmaceutical company that develops new targeted therapeutics based on cell state and ferroptosis biology.
2020
$60M
from 5 investors over 5 rounds
Kojin Therapeutics raised $60M on June 9, 2021
Investors: Newpath Partners, Leaps by Bayer, Eventide Asset Management, Cathay Capital and Polaris Partners